Inactive Instrument

BioElectronics Corporation Stock Other OTC

Equities

BIEL

US09062H1086

Advanced Medical Equipment & Technology

Sales 2020 830K Sales 2021 1.61M Capitalization 25.6M
Net income 2020 -1M Net income 2021 - EV / Sales 2020 53.6 x
Net Debt 2020 13.07M Net Debt 2021 13.34M EV / Sales 2021 24.2 x
P/E ratio 2020
-26.5 x
P/E ratio 2021
-95.5 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study CI
Bioelectronics Corporation Announces the Publication of Pilot Study Results CI
BioElectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
BioElectronics Corporation Enters into a Distribution Agreement for RecoveryRx in Spain with Prim Group CI
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico CI
BioElectronics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
BioElectronics Corporation Reports Revenue Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
BioElectronics Corporation Reports Revenue Results for the Second Quarter and Six Months Ended June 30, 2021 CI
BioElectronics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
BioElectronics Corporation Reports Revenue Results for the First Quarter of 2021 CI
Bioelectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2020 CI
BioElectronics Corporation Reports Revenue Results for the Fourth Quarter of 2020 CI
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market CI
BioElectronics' ActiPatch Therapy To Be Marketed By DonJoy Advantage CI
Bioelectronics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 19-11-14
Sales & Marketing - 17-08-31
Corporate Officer/Principal - 02-03-31
Members of the board TitleAgeSince
Chairman 83 20-06-14
Sales & Marketing - 17-08-31
Chief Executive Officer - 19-11-14
More insiders
BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy, is developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The Company is also focused on international customers to expand its distributions and sales. The neuromodulation basis of PSWT presents significant opportunities for it to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.
More about the company